Latest stories on LRMR
Larimar Therapeutics GAAP EPS of -$0.30 beats by $0.09
Seeking Alpha58 · neutralearnings
Larimar Therapeutics, Inc. (LRMR) files 8-K
SEC 8-K50 · neutralgeneral
Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
Business Insider59 · neutralgeneral
LRMR Options Prices for Larimar Therapeutics Stock
Barchart50 · neutralgeneral
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy
Yahoo Finance67 · bullishproduct/pr
LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000
Stocktwits News56 · neutralgeneral
Here’s What Citi Thinks About Larimar Therapeutics (LRMR)
Yahoo Top61 · neutralanalyst
LRMR Shares Hold Steady As Wall Street Optimism Offsets Drug Safety Concerns
Stocktwits News58 · neutralanalyst
Larimar Therapeutics, Inc. (LRMR) Discusses Regulatory Progress and Long-Term Data for Nomlabofusp in Friedreich's Ataxia - Slideshow
Seeking Alpha65 · bullishproduct/pr
Larimar Therapeutics: Late-Stage FA Program Advances Amid Execution Risks
Seeking Alpha58 · neutralproduct/pr
Larimar Therapeutics, Inc. (LRMR) Discusses Regulatory Progress and Long-Term Data for Nomlabofusp in Friedreich's Ataxia Transcript
Seeking Alpha63 · neutralproduct/pr
Larimar's Rare Disease Push Just Hit A Key Inflection Point — What Investors Need To Know
Stocktwits News67 · bullishproduct/pr
Larimar Advances Nomlabofusp BLA Toward Accelerated Approval
TipRanks73 · bullishproduct/pr
Larimar Therapeutics, Inc. (LRMR) files 8-K
SEC 8-K50 · neutralgeneral
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia | LRMR Stock News
StockTitan56 · neutralproduct/pr
LRMR: [Form 4] Larimar Therapeutics, Inc. Insider Trading Activity
StockTitan SEC50 · neutralgeneral
Larimar Therapeutics GAAP EPS of -$0.31 beats by $0.23
Seeking Alpha68 · bullishearnings